临床医生在诊断其他性传播疾病时，会对医疗补助计划的患者进行梅毒或艾滋病毒筛查吗？
Do clinicians screen Medicaid patients for syphilis or HIV when they diagnose other sexually transmitted diseases?
作者信息
Rust George, Minor Patrick, Jordan Neil, Mayberry Robert, Satcher David
机构信息
National Center for Primary Care at Morehouse School of Medicine, Atlanta, Georgia 30310, USA.
出版信息
Sex Transm Dis. 2003 Sep;30(9):723-7. doi: 10.1097/01.OLQ.0000078652.66397.4C.
BACKGROUND
Patients diagnosed with gonorrhea or chlamydia are at high risk for HIV and syphilis, and should be offered screening for both.
GOAL
This study measures HIV and syphilis screening rates among Medicaid patients diagnosed with another sexually transmitted disease (STD).
STUDY DESIGN
Using 1998 Medicaid claims data from 4 states, we identified individuals diagnosed with gonorrhea, urogenital chlamydia, or pelvic inflammatory disease, and then measured the proportion receiving screening tests for HIV and syphilis.
RESULTS
Only 25% of STD-diagnosed Medicaid patients received screening tests for syphilis and only 15% for HIV. We found significant state-to-state variability in screening rates.
CONCLUSION
Medicaid patients diagnosed with a nonbloodborne STD represent a high-risk group that is not adequately screened for syphilis and HIV despite repeated contact with medical professionals. Interventions should focus on eliminating missed opportunities for screening these high-risk individuals.
背景
被诊断患有淋病或衣原体感染的患者感染艾滋病毒和梅毒的风险很高，应同时接受这两种疾病的筛查。
目标
本研究测量了被诊断患有另一种性传播疾病（STD）的医疗补助患者的艾滋病毒和梅毒筛查率。
研究设计
利用来自4个州的1998年医疗补助索赔数据，我们确定了被诊断患有淋病、泌尿生殖道衣原体感染或盆腔炎的个体，然后测量了接受艾滋病毒和梅毒筛查测试的比例。
结果
仅25%被诊断患有性传播疾病的医疗补助患者接受了梅毒筛查测试，仅15%接受了艾滋病毒筛查测试。我们发现各州之间的筛查率存在显著差异。
结论
被诊断患有非血源传播性传播疾病的医疗补助患者是一个高危群体，尽管他们多次接触医疗专业人员，但对梅毒和艾滋病毒的筛查仍不充分。干预措施应侧重于消除对这些高危个体的筛查遗漏机会。
Zotero 插件